KLK3 and prostate carcinoma: Adjusting PSA for both age and BMI showed similar results to adjusting solely for age, with the exception of improved sensitivity at 4.0 ng/ml, implying that adjusting for BMI as well as age did not materially improve the discrimination of PSA for prostate cancer.